Investigating The Experiences of Patients In Immunotherapy Clinical Trials
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPower Life Sciences Inc.
About this trial
It has been observed before that participation in medical trials has been in favor of specific demographic groups. But research pointing out which trial attributes impact participation positively or negatively is sparse.
This study invites various participants to collect more data on their immunotherapy clinical experiences. The goal is to know which factors always limit how patients participate or complete the medical study they are first interested in.
The data obtained in the trial will be assessed through a variety of demographic lenses to discover patterns that might improve the experience of immunotherapy patients in the future.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient has self-identified as planning to participate in an interventional clinical trial using immunotherapy
Patient has been diagnosed with a type of cancer
Patient is a minimum of 18 years or older
Disqualifiers
Patient has an ECOG score of 4 or higher
Patient is not able to provide consistent digital reporting as per study requirements
Patient does not complete Informed Consent Form
Trial population
Patients with cancer who are actively considering enrolling in an immunotherapy interventional clinical trials, but have not yet completed enrollment and randomization in said clinical trial.
Trial design
Design model
Case-crossover
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Number of patients who decide to enroll in an immunotherapy clinical trial
Time frame
3 months2
Rate of patients who remain in immunotherapy clinical trial to trial completion
Time frame
12 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: